Search research articles
Contact Us
Filters
Showing results (821-830 of 1,012) with videos related to
Page
of 102
Sort By:
BMC Cancer
|
September 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma
Julia Wendler, Christopher P Fox, Elke Valk, et al.
JAMA Dermatology
|
December 5, 2019
Effect of Topical Brimonidine on Alcohol-Induced Flushing in Asian Individuals: A Randomized Clinical Trial
Wesley Y Yu, Brian Lu, Daniel Tan, et al.
RMD Open
|
March 7, 2024
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
Abhishek Abhishek, Matthew Grainge, Tim Card, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 22, 2024
USING SPUTUM AND TONGUE SWAB SPECIMENS FOR IN-HOME POINT-OF-CARE TARGETED UNIVERSAL TESTING FOR TB OF HOUSEHOLD CONTACTS: AN ACCEPTABILITY AND FEASIBILITY ANALYSIS
Charl Bezuidenhout, Lawrence Long, Brooke Nichols, et al.
AIDS (London, England)
|
August 5, 2010
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007
Morna Cornell, Anna Grimsrud, Lara Fairall, et al.
BMJ Open
|
June 12, 2017
Cohort profile: the Right to Care Clinical HIV Cohort, South Africa
Matthew P Fox, Mhairi Maskew, Alana T Brennan, et al.
Nature Communications
|
November 6, 2025
Mycobacterium tuberculosis transmission in China during the COVID-19 pandemic period (2020-2021) compared with the pre-pandemic period (2017-2019)
Qiao Liu, Wenjin Wang, Kristin Nelson, et al.
Epidemiology (Cambridge, Mass.)
|
October 21, 2015
Evaluation of Selection Bias in an Internet-based Study of Pregnancy Planners
Elizabeth E Hatch, Kristen A Hahn, Lauren A Wise, et al.
Infectious Diseases (London, England)
|
September 22, 2025
Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation
Amy Zheng, Alana T Brennan, Ross Greener, et al.
Bone Marrow Transplantation
|
February 23, 2016
Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT
D M Burns, S Rana, E Martin, et al.
Page
of 102
Search research articles
Search
Showing results (821-830 of 1,012) with videos related to
Sort By:
Page
of 102
BMC Cancer
|
September 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma
Julia Wendler, Christopher P Fox, Elke Valk, et al.
JAMA Dermatology
|
December 5, 2019
Effect of Topical Brimonidine on Alcohol-Induced Flushing in Asian Individuals: A Randomized Clinical Trial
Wesley Y Yu, Brian Lu, Daniel Tan, et al.
RMD Open
|
March 7, 2024
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
Abhishek Abhishek, Matthew Grainge, Tim Card, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 22, 2024
USING SPUTUM AND TONGUE SWAB SPECIMENS FOR IN-HOME POINT-OF-CARE TARGETED UNIVERSAL TESTING FOR TB OF HOUSEHOLD CONTACTS: AN ACCEPTABILITY AND FEASIBILITY ANALYSIS
Charl Bezuidenhout, Lawrence Long, Brooke Nichols, et al.
AIDS (London, England)
|
August 5, 2010
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007
Morna Cornell, Anna Grimsrud, Lara Fairall, et al.
BMJ Open
|
June 12, 2017
Cohort profile: the Right to Care Clinical HIV Cohort, South Africa
Matthew P Fox, Mhairi Maskew, Alana T Brennan, et al.
Nature Communications
|
November 6, 2025
Mycobacterium tuberculosis transmission in China during the COVID-19 pandemic period (2020-2021) compared with the pre-pandemic period (2017-2019)
Qiao Liu, Wenjin Wang, Kristin Nelson, et al.
Epidemiology (Cambridge, Mass.)
|
October 21, 2015
Evaluation of Selection Bias in an Internet-based Study of Pregnancy Planners
Elizabeth E Hatch, Kristen A Hahn, Lauren A Wise, et al.
Infectious Diseases (London, England)
|
September 22, 2025
Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation
Amy Zheng, Alana T Brennan, Ross Greener, et al.
Bone Marrow Transplantation
|
February 23, 2016
Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT
D M Burns, S Rana, E Martin, et al.
Page
of 102